137 related articles for article (PubMed ID: 31295576)
1. Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.
Munden RF; Chiles C; Boiselle PM; Sicks JD; Aberle DR; Gatsonis CA
J Thorac Oncol; 2019 Sep; 14(9):1538-1546. PubMed ID: 31295576
[TBL] [Abstract][Full Text] [Related]
2. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
[TBL] [Abstract][Full Text] [Related]
3. Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer.
Chalian H; McAdams HP; Lee Y; Duan F; Wu Y; Khoshpouri P; Patz EF
Radiology; 2022 Mar; 302(3):684-692. PubMed ID: 34812667
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
5. Results of initial low-dose computed tomographic screening for lung cancer.
; Church TR; Black WC; Aberle DR; Berg CD; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gierada DS; Jones GC; Mahon I; Marcus PM; Sicks JD; Jain A; Baum S
N Engl J Med; 2013 May; 368(21):1980-91. PubMed ID: 23697514
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial.
Nguyen XV; Davies L; Eastwood JD; Hoang JK
J Am Coll Radiol; 2017 Mar; 14(3):324-330. PubMed ID: 28259326
[TBL] [Abstract][Full Text] [Related]
7. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
Yip R; Henschke CI; Yankelevitz DF; Smith JP
Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
[TBL] [Abstract][Full Text] [Related]
8. Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1).
dos Santos RS; Franceschini JP; Chate RC; Ghefter MC; Kay F; Trajano AL; Pereira JR; Succi JE; Fernando HC; Júnior RS
Ann Thorac Surg; 2016 Feb; 101(2):481-6; discussion 487-8. PubMed ID: 26409711
[TBL] [Abstract][Full Text] [Related]
9. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.
Gierada DS; Pinsky PF; Duan F; Garg K; Hart EM; Kazerooni EA; Nath H; Watts JR; Aberle DR
Eur Radiol; 2017 Aug; 27(8):3249-3256. PubMed ID: 28050695
[TBL] [Abstract][Full Text] [Related]
10. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
11. Validation of a Deep Learning Algorithm for the Detection of Malignant Pulmonary Nodules in Chest Radiographs.
Yoo H; Kim KH; Singh R; Digumarthy SR; Kalra MK
JAMA Netw Open; 2020 Sep; 3(9):e2017135. PubMed ID: 32970157
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
Goldwasser DL
Int J Cancer; 2017 Mar; 140(6):1280-1292. PubMed ID: 27925181
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
14. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
15. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
Gierada DS; Pinsky PF
Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
[TBL] [Abstract][Full Text] [Related]
16. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
17. National lung screening trial: variability in nodule detection rates in chest CT studies.
Pinsky PF; Gierada DS; Nath PH; Kazerooni E; Amorosa J
Radiology; 2013 Sep; 268(3):865-73. PubMed ID: 23592767
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
19. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
